- The AIRNA Team
- Board of Directors
- Founders
- Investors
A team that is passionate about restoring patient health.
Aindrila_Chatterjee
Senior Scientist
Andrea Armstrong
Interim Chief People Officer
Devyn Smith
Arbor Bio
Thorsten Stafforst
Founder
Eric Moessinger
ND Capital
Christopher Volkert
Research Associate
Jin Billy Li
Founder
Gabriela Ecco
ND Capital (Observer)
Daniella Mizurini
Senior Scientist
Keith L. Crandell
ARCH Venture Partners (Observer)
Dirk Lindenblatt
Scientist
“RNA editing has unique potential to make transformative medicines for many patients”
Rodger Novak
Elena Poser
Principal Scientist
Elisangela Bressan
Senior Scientist
Eva-Maria Duerr
Scientist
Fernanda Sachenbacher
Senior Scientist
Inga Jarmoskaite
Senior Scientist
Juri Eyberg
Scientist
Kaiko Kunii
In Vivo Pharmacologist
One Airna
Konstantin Licht
Senior Scientist
“RNA editing opens a world of possibilities never seen before”
Thorsten Stafforst, Founder
Kris Elverum
President and CEO
Kris Elverum
President and CEO
Reetika Bhardwaj
ARCH Venture Partners (Observer)
Lena Fischer
Sr. Director Finance & Operations
Rodger Novak
Entrepreneur
Sean Kendall
ARCH Venture Partners
Li-Hao Chang
Scientist
Luise Stafforst
Lab manager
Martina Buttschardt
Research Associate
Namita Bisaria
Vice President, Strategy & Program Management
Negin Namazian
Sr. Research Associate
Patrick Foster
Vice President of CMC
Paul Vogel
VP Research & Managing Director
Thorsten Stafforst
Founder
Paul Vogel
VP Research & Managing Director
Peter Borsos
Research Associate
Piotr Putaj
Associate Director
Rewati Tappu
Senior Scientist
Robert Altshuler
Head of Computational Biology
Sriram Sathy
CSO
Sruthi V. Hindupur
Scientist
Stephen Su
Senior Director, Target Validation
Tobias Merkle
Senior Director, Platform Development
Tobias Merkle
Senior Director, Platform Development
Tracey Lynn Sullivan
Executive Assistant & Office Manager
Veronica Giachin
Research Associate
Victor De Jesus
Associate Scientist
TRANSFORMING LIVES,
ONE TEAMMATE AT A TIME